WuXi Biologics
WuXi Biologics is a open-access technology platform company offering end-to-end solutions to empower organizations to discover and develop.
Business Model:
Revenue: $368.5M
Employees: 1,001-5,000
Rankings
Industries / Tags:
Detailed WuXi Biologics Information
Geographic Data
Address: 108 Meiliang Road. W,
City: Wuxi
State: shanghai municipality
Zip: 214092
Country: CN
Financial Info
Stage:
Raised Last:
$0
Raised Total:$511M
Social
Linkedin
Crunchbase
Metrics
1,351,267Website Global Rank
20,844Website Monthly Traffic
Twitter Followers
Description
WuXi Biologics is a open-access technology platform company offering end-to-end solutions to empower organizations to discover, develop, and manufacture biologics from concept to commercial manufacturing. Across the global biologics research and development community, we enable our partners to find innovative biological treatments for diseases worldwide.
Contact Phone:
Contact Email:
WuXi Biologics went public on 6/16/2017 on the HKG
Listed Exchange:
HKG
IPO Date:
6/16/2017
Ticker Symbol:
2269
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 2/2020 | Invetx | Series A | 0 |
| 5/2021 | Duality Biologics | Series B | 0 |
| 4/2019 | Duoning Biotech | Series A | 0 |
| 5/2019 | Inhibrx | Private Placement | 40M |
| 9/2020 | Invetx | Series A | 0 |
| 5/2021 | Duality Biologics | Series B | 0 |
| 9/2020 | Invetx | Series A | 0 |
| 2/2020 | Invetx | Series A | 0 |
| 5/2019 | Inhibrx | Convertible Note | 0 |
| 4/2019 | Duoning Biotech | Series A | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
